Management of Helicobacter pylori treatment failures: A large population-based study (HP treatment failures trial)
PLOS ONE · 30.11.2023 · 18 (11) · e0294403
DOI: 10.1371/journal.pone.0294403 ↗Kurz gefasst
Klinische Studie in der Zeitschrift PLOS ONE, online erschienen am 30.11.2023. Verfasst von Natsuda Aumpan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center of Excellence in Digestive Diseases and Gastroenterology Unit, Department of Medicine, Thammasat University, Pathumthani, Thailand. Hauptthemen laut MEDLINE: Helicobacter Infections, Helicobacter pylori. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development (AMED) [e-ASIA JRP], Thailand Science Research and Innovation Fundamental Fund, Bualuang ASEAN Chair Professorship at Thammasat University.
Abstract (Originalsprache)
Background
Helicobacter pylori treatment failure remains a challenging problem. This study aimed to identify predictive factors for successful eradication in patients following treatment failures.
Methods
This was a retrospective cohort study. This study included 1,050 dyspeptic patients diagnosed with H . pylori infection at tertiary care center in Thailand between March 2014 and October 2021. Patients’ demographic data, endoscopic findings, H . pylori culture, antimicrobial susceptibility testing (AST), treatment regimens and outcomes were analysed.
Results
Of 1,050 patients with H . pylori infections, 302 (28.7%) experienced treatment failure (mean age 58.4 years; 44.7% males). AST was performed in 192. Resistance was observed for metronidazole (43.2%), levofloxacin (33.9%), clarithromycin (24%), and amoxicillin (2.1%). There was no tetracycline resistance. Multidrug-resistance (MDR) was significantly more common following treatment failure (45.5% vs. 15.7%, p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center of Excellence in Digestive Diseases and Gastroenterology Unit, Department of Medicine, Thammasat University, Pathumthani, Thailand.
- Department of Medicine, Chulabhorn International College of Medicine (CICM) at Thammasat University, Pathumthani, Thailand.
- Department of Medicine, Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston, Texas, United States of America.
- Department of Environmental and Preventive Medicine, Oita University Faculty of Medicine, Yufu, Japan.
- Research Center for Global and Local Infectious Diseases, Oita University, Yufu, Japan.
ORCID-Profile: Natsuda Aumpan, Yoshio Yamaoka, Ratha-Korn Vilaichone
Förderung
- Japan Agency for Medical Research and Development (AMED) [e-ASIA JRP]
- Thailand Science Research and Innovation Fundamental Fund
- Bualuang ASEAN Chair Professorship at Thammasat University
- Center of Excellence in Digestive Diseases, Thammasat University, Thailand
Zitieren
APA
Aumpan, N., Issariyakulkarn, N., Mahachai, V., Graham, D., Yamaoka, Y., & Vilaichone, R. K. (2023). Management of Helicobacter pylori treatment failures: A large population-based study (HP treatment failures trial). PLOS ONE, 18(11), e0294403. https://doi.org/10.1371/journal.pone.0294403
Vancouver
Aumpan N, Issariyakulkarn N, Mahachai V, Graham D, Yamaoka Y, Vilaichone RK. Management of Helicobacter pylori treatment failures: A large population-based study (HP treatment failures trial). PLOS ONE. 2023;18(11):e0294403. doi:10.1371/journal.pone.0294403
BibTeX
@article{Aumpan2023,
author = {Aumpan, Natsuda and Issariyakulkarn, Navapan and Mahachai, Varocha and Graham, David and Yamaoka, Yoshio and Vilaichone, Ratha-Korn},
title = {Management of Helicobacter pylori treatment failures: A large population-based study (HP treatment failures trial)},
journal = {PLOS ONE},
year = {2023},
volume = {18},
number = {11},
pages = {e0294403},
doi = {10.1371/journal.pone.0294403}
}
EUVIMED